EUCTR2007-000842-11-AT进行中（未招募）1 期
99Tc labled Inliximab for evaluation of inflammatory activity in patients with inflammtory bowel disease (IBD)
Medical University of Graz0 个研究点开始时间: 2007年9月4日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •active inflammatory bowel disease
- •age over 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •immune deficiency, allergy to infliximab, malignancy, severe infections, pregnancy
研究者
相似试验
进行中（未招募）
不适用
Diagnostic use of 99mTecnetium labeled infliximab in Crohn’s diseaseEUCTR2013-005629-21-HUFirst Department of Medicine, University of Szeged
已完成
不适用
Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's ColitisInflammatory Bowel Diseases10017969NL-OMON37225Academisch Medisch Centrum12
进行中（未招募）
1 期
Accelerated infliximab infusions in inflammatory bowel diseaseInflammatory bowel diseasesEUCTR2021-000570-28-FITampere University Hospital130
尚未招募
4 期
The course of Disease Activity, infliximab serum concentrations and anti-infliximab antibody concentrations measured, between two standard infliximab infusion time- periods, in patients with rheumatoid arthritis.10023213Rheumatoid ArthritisNL-OMON31619Sint Maartenskliniek25
进行中（未招募）
不适用
Measurement of levels of infliximab and anti-infliximab antibodies inrheumatic patientsEUCTR2013-004969-14-FIHeidi Mäkinen150